HLA-DRB1 and rheumatoid arthritis: In terms of TNFi efficacy, a study using a UK RA cohort found significant disease activity improvement with TNFi therapy when valine, lysine and alanine were at positions 11, 71, and 74 of HLA-DRB1, respectively (97).